Prediction of conditional survival in esophageal cancer in a population-based cohort study

被引:0
|
作者
Xie, Shao-Hua [1 ,2 ,3 ]
Santoni, Giola [3 ]
Bottai, Matteo [4 ]
Gottlieb-Vedi, Eivind [3 ]
Lagergren, Pernilla [3 ,5 ]
Lagergren, Jesper [3 ,6 ]
机构
[1] Fujian Med Univ, School Publ Hlth, Fuzhou, Peoples R China
[2] Fujian Med Univ, Key Lab Minist Educ Gastrointestinal Canc, Fuzhou, Peoples R China
[3] Karolinska Univ Hosp, Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden
[4] Karolinska Inst, Inst Environm Med, Div Biostat, Stockholm, Sweden
[5] Imperial Coll London, Dept Surg & Canc, Fac Med, London, England
[6] Kings Coll London, Sch Canc & Pharmaceut Sci, Guys Hosp Campus, London, England
基金
瑞典研究理事会;
关键词
esophageal neoplasm; mortality; prognosis; prognostic factors; NEOADJUVANT CHEMORADIOTHERAPY; SURGERY; ADENOCARCINOMA; CHEMOTHERAPY; MORBIDITY; NOMOGRAM;
D O I
10.1097/JS9.0000000000000347
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: The authors aimed to produce a prediction model for survival at any given date after surgery for esophageal cancer (conditional survival), which has not been done previously. Materials and Methods: Using joint density functions, the authors developed and validated a prediction model for all-cause and disease-specific mortality after surgery with esophagectomy, for esophageal cancer, conditional on postsurgery survival time. The model performance was assessed by the area under the receiver operating characteristic curve (AUC) and risk calibration, with internal cross-validation. The derivation cohort was a nationwide Swedish population-based cohort of 1027 patients treated in 1987-2010, with follow-up throughout 2016. This validation cohort was another Swedish population-based cohort of 558 patients treated in 2011-2013, with follow-up throughout 2018. Results: The model predictors were age, sex, education, tumor histology, chemo(radio)therapy, tumor stage, resection margin status, and reoperation. The medians of AUC after internal cross-validation in the derivation cohort were 0.74 (95% CI: 0.69-0.78) for 3-year all-cause mortality, 0.76 (95% CI: 0.72-0.79) for 5-year all-causemortality, 0.74 (95% CI: 0.70-0.78) for 3-year disease-specificmortality, and 0.75 (95% CI: 0.72-0.79) for 5-year disease-specificmortality. The corresponding AUC values in the validation cohort ranged from 0.71 to 0.73. The model showed good agreement between observed and predicted risks. Complete results for conditional survival any given date between 1 and 5 years of surgery are available from an interactive web-tool: https://sites.google.com/view/pcsec/home. Conclusion: This novel prediction model provided accurate estimates of conditional survival any time after esophageal cancer surgery. The web-tool may help guide postoperative treatment and follow-up.
引用
收藏
页码:1141 / 1148
页数:8
相关论文
共 50 条
  • [21] Racial disparities in conditional survival of patients with bladder cancer: a population-based study
    Wei Liu
    Jie Xiong
    Honghao Wang
    Shuo Li
    Zhentao Lei
    Lili Jiang
    Jin Cao
    Lin Yang
    Hongfeng Guo
    Qiang Gao
    Shenghan Wang
    Bao Zhang
    [J]. BMC Urology, 23
  • [22] Racial disparities in conditional survival of patients with bladder cancer: a population-based study
    Liu, Wei
    Xiong, Jie
    Wang, Honghao
    Li, Shuo
    Lei, Zhentao
    Jiang, Lili
    Cao, Jin
    Yang, Lin
    Guo, Hongfeng
    Gao, Qiang
    Wang, Shenghan
    Zhang, Bao
    [J]. BMC UROLOGY, 2023, 23 (01)
  • [23] Conditional Survival and Cure of Patients With Colon or Rectal Cancer: A Population-Based Study
    Qaderi, Seyed M.
    Dickman, Paul W.
    de Wilt, Johannes Hw
    Verhoeven, Rob H. A.
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2020, 18 (09): : 1230 - 1237
  • [24] Age-specific incidence, treatment, and survival trends in esophageal cancer: a Dutch population-based cohort study
    Al-Kaabi, Ali
    Baranov, Nikolaj S.
    van der Post, Rachel S.
    Schoon, Erik J.
    Rosman, Camiel
    van Laarhoven, Hanneke W. M.
    Verheij, Marcel
    Verhoeven, Rob H. A.
    Siersema, Peter D.
    [J]. ACTA ONCOLOGICA, 2022, 61 (05) : 545 - 552
  • [25] Social Inequalities in Cancer Survival in Belgium: A Population-Based Cohort Study
    Rosskamp, Michael
    Verbeeck, Julie
    Sass, Victoria
    Gadeyne, Sylvie
    Verdoodt, Freija
    De Schutter, Harlinde
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2021, 30 (01) : 45 - 52
  • [26] Survival of male breast cancer patients: Population-based cohort study
    Thalib, Lukman
    Hall, Per
    [J]. CANCER SCIENCE, 2009, 100 (02) : 292 - 295
  • [27] Antimuscarinics and lung cancer survival: A Norwegian population-based cohort study
    Sanjinez, Claudia
    Botteri, Edoardo
    Stoer, Nathalie C.
    Lofling, L. Lukas
    [J]. LUNG CANCER, 2023, 179
  • [28] Are alarm symptoms predictive of cancer survival? Population-based cohort study
    Dregan, Alex
    Moller, Henrik
    Charlton, Judith
    Gulliford, Martin C.
    [J]. BRITISH JOURNAL OF GENERAL PRACTICE, 2013, 63 (617): : E807 - E812
  • [29] Osteonecrosis Of The Jaw And Cancer Survival: A Danish Population-Based Cohort Study
    Corraini, Priscila
    Heide-Jorgensen, Uffe
    Schiodt, Morten
    Norholt, Sven Erik
    Sorensen, Henrik Toft
    Ehrenstein, Vera
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 98 - 99
  • [30] Esophageal cancer after sleeve gastrectomy: a population-based comparative cohort study
    Andalib, Amin
    Bouchard, Philippe
    Demyttenaere, Sebastian
    Ferri, Lorenzo E.
    Court, Olivier
    [J]. SURGERY FOR OBESITY AND RELATED DISEASES, 2021, 17 (05) : 879 - 887